<DOC>
	<DOC>NCT01497990</DOC>
	<brief_summary>This study will examine the pharmacokinetics of ertapenem in ventilated badly (&gt; 30% SCT) burn patients.</brief_summary>
	<brief_title>Pharmacokinetics Ertapenem Burns</brief_title>
	<detailed_description />
	<mesh_term>Burns</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<criteria>Patients aged 18 to 70 years Burned on 30 to 60% of their body surface Mechanical ventilation Hospitalized in the intensive care unit of Nantes University Hospital for less than 8 days. Which the family gave consent insured Patients whose family refused to sign the consent for participation. Patients allergic to beta lactam Patients with renal failure with creatinine clearance &lt;80 ml.mn1 Pregnant women Persons protected by the law</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Burns</keyword>
	<keyword>Ertapenem</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>